Dr. Jacob Berchuck
Company: Dana-Farber Cancer Institute
Job title: Instructor in Medicine
Seminars:
Panel Discussion & Q&A: Emergence of Novel Clinical Biomarkers- Molecular Response, Methylation, MRD 2:55 pm
The objective of this session is to expound on the field of novel predictive and prognostic biomarkers that would aid in the identification of late-stage cancer patients who would respond to the ever-growing repertoire of therapies that includes next-generation immunotherapies, epigenetic modulators, and bi-specific antibodies. The panel will discuss the current and future state of…Read more
day: Guardant Health Afternoon Workshop
Clinical Actionability of cfDNA Methylation Analysis 2:35 pm
day: Guardant Health Afternoon Workshop